The Faroese IBD Study: Incidence of Inflammatory Bowel Diseases Across 54 Years of Population-based Data
- PMID: 26933031
- PMCID: PMC4962362
- DOI: 10.1093/ecco-jcc/jjw050
The Faroese IBD Study: Incidence of Inflammatory Bowel Diseases Across 54 Years of Population-based Data
Abstract
Background and aims: Inflammatory bowel diseases [IBDs] include Crohn's disease [CD], ulcerative colitis [UC], and IBD unclassified [IBDU]. In 2010 and 2011, the ECCO-EpiCom study found the worldwide highest incidence of inflammatory bowel disease [IBD] in the Faroe Islands: 83 per 100 000 [European Standard Population, ESP]. The present study assessed the long-term time trends in IBD incidence in the Faroese population.
Methods: In this population-based study, data were retrieved from the National Hospital of the Faroe Islands and included all incident cases of CD, UC, and IBDU diagnosed between July 1960 and July 2014. Patients of all ages were included and diagnoses were defined according to the Copenhagen Diagnostic Criteria.
Results: A total of 664 incident IBD patients were diagnosed: 113 with CD, 417 with UC, and 134 with IBDU. Of these, 51 [8%] were diagnosed with paediatric-onset IBD. Between 1960 and 1979, a total of 55 persons were diagnosed; 105 in 1980-89; 166 in 1990-99; 180 in 2000-09; and 158 in 2010-14. This represented an increase in the age-standardised IBD incidence rate from 7, 25, 40, and 42 to 74 per 100 000 [ESP]. For CD, the increase was from 1 to 10, for UC from 4 to 44, and for IBDU from 2 to 21 per 100 000 [ESP].
Conclusions: The high IBD incidence was found to be a relatively new phenomenon. The observed increase is unlikely to be an artefact resulting from, for instance, better registration. Our study indicated a real and increasing disease burden resulting from changing-so far unidentified-exposures.
Keywords: Epidemiology; Faroe Islands; inflammatory bowel diseases.
© European Crohn’s and Colitis Organisation 2016.
Figures






Similar articles
-
Inflammatory bowel diseases in Faroese-born Danish residents and their offspring: further evidence of the dominant role of environmental factors in IBD development.Aliment Pharmacol Ther. 2017 Apr;45(8):1107-1114. doi: 10.1111/apt.13975. Epub 2017 Feb 8. Aliment Pharmacol Ther. 2017. PMID: 28176348 Free PMC article.
-
Incidence and phenotype at diagnosis of inflammatory bowel disease. Results in Spain of the EpiCom study.Gastroenterol Hepatol. 2015 Nov;38(9):534-40. doi: 10.1016/j.gastrohep.2015.03.001. Epub 2015 Apr 15. Gastroenterol Hepatol. 2015. PMID: 25890448
-
The Incidence and Prevalence of Inflammatory Bowel Disease Continues to Increase in the Faroe Islands - A Cohort Study from 1960 to 2020.J Crohns Colitis. 2024 Feb 26;18(2):308-319. doi: 10.1093/ecco-jcc/jjad155. J Crohns Colitis. 2024. PMID: 37667976
-
The epidemiology of inflammatory bowel disease.Scand J Gastroenterol. 2015 Aug;50(8):942-51. doi: 10.3109/00365521.2015.1014407. Epub 2015 Feb 17. Scand J Gastroenterol. 2015. PMID: 25687629 Review.
-
Paediatric inflammatory bowel disease: review with a focus on practice in low- to middle-income countries.Paediatr Int Child Health. 2019 Feb;39(1):48-58. doi: 10.1080/20469047.2019.1575056. Paediatr Int Child Health. 2019. PMID: 30900526 Review.
Cited by
-
FarGen: Elucidating the distribution of coding variants in the isolated population of the Faroe Islands.Eur J Hum Genet. 2023 Mar;31(3):329-337. doi: 10.1038/s41431-022-01227-2. Epub 2022 Nov 21. Eur J Hum Genet. 2023. PMID: 36404349 Free PMC article.
-
The Natural History of IBD: Lessons Learned.Curr Treat Options Gastroenterol. 2018 Mar;16(1):101-111. doi: 10.1007/s11938-018-0173-3. Curr Treat Options Gastroenterol. 2018. PMID: 29359275 Review.
-
CD169 Expressing Macrophage, a Key Subset in Mesenteric Lymph Nodes Promotes Mucosal Inflammation in Dextran Sulfate Sodium-Induced Colitis.Front Immunol. 2017 Jun 26;8:669. doi: 10.3389/fimmu.2017.00669. eCollection 2017. Front Immunol. 2017. PMID: 28694804 Free PMC article.
-
Current global trends in the incidence of pediatric-onset inflammatory bowel disease.World J Gastroenterol. 2018 Jul 7;24(25):2741-2763. doi: 10.3748/wjg.v24.i25.2741. World J Gastroenterol. 2018. PMID: 29991879 Free PMC article. Review.
-
TAK-242 ameliorates DSS-induced colitis by regulating the gut microbiota and the JAK2/STAT3 signaling pathway.Microb Cell Fact. 2020 Aug 6;19(1):158. doi: 10.1186/s12934-020-01417-x. Microb Cell Fact. 2020. PMID: 32762699 Free PMC article.
References
-
- Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012;142:46–54. - PubMed
-
- Burisch J, Munkholm P. The epidemiology of inflammatory bowel disease. Scand J Gastroenterol 2015;50:942–51. - PubMed
-
- Burisch J, Jess T, Martinato M, Lakatos PL; ECCO-EpiCom The burden of inflammatory bowel disease in Europe. J Crohns Colitis 2013;7:322–37. - PubMed
-
- Burisch J, Pedersen N, Čuković-Čavka S, et al. ; EpiCom-group East- West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO- EpiCom inception cohort. Gut 2014;63:588–97. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources